CogState signs $400,000 functional food deal
Monday, 13 February, 2006
CogState (ASX:CGS) is to provide cognition testing services to a European food products company in a contract worth more than AUD$400,000.
Over the next 12 to 15 months, Cogstate will be studying the effect of the European company's dietary product on cognitive function in a trial conducted at the Murdoch Children's Research Institute, Melbourne.
If the trial demonstrates cognitive function enhancement as a result of people consuming its dietary supplement, the food products company will be able to make marketing claims in relation to the product.
Oxytocin analogue treats chronic abdominal pain
Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain,...
'Low-risk' antibiotic linked to rise of dangerous superbug
A new study has challenged the long-held belief that rifaximin — commonly prescribed to...
Robotic hand helps cultivate baby corals for reef restoration
The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...